Senyawa Metabolit Sekunder dan Aspek Farmakologi dari Alocasia macrorrhizos
Abstract
Keywords
Full Text:
Full TextReferences
P. C. Boyce, “A review of Alocasia (Araceae: Colocasieae) for Thailand including a novel species and new species records from South-west Thailand,” Thai Forest Bulletin (Botany), vol. 36, pp. 1-17, 2008.
M. Rahmatullah et al., “An ethnomedicinal survey of dhamrai sub-district in Dhaka District, Bangladesh,” American-Eurasian Journal of Sustainable Agriculture, vol. 3, pp. 881-888, 2009.
A. Hay and R Wise, “The genus Alocasia (Araceae) in Australia,” Blumea, vol. 35, pp. 499-545, 1991.
S. Chotimah and D. T. Fajarini, “Reduksi kalsium oksalat dengan perebusan menggunakan larutan NaCl dan penepungan untuk meningkatkan kualitas sente (Alocasia macrorrhiza) sebagai bahan pangan,” Jurnal Teknologi Kimia dan Industri, vol. 2, pp. 76-83, 2013.
M. Rahman, et al., “Antihyperglycemic, antioxidant, and cytotoxic activities of Alocasia macrorrhizos (L.) rhizome extract,” Turk J Biol., vol. 36, pp. 574-579, 2012.
S. Pal, et al., “Antioxidant and hepatoprotective activity of ethanolic extract of Alocasia indica tuber,” American Journal of Phytomedicine and Clinical Therapeutics, vol. 2, pp. 191-208, 2014.
D. M. Kaaiakamanu and J. K. Akina, “Hawaiian herbs of medicinal value,” Hawaii: University Press of the Pasific Honolulu, 2003.
W. A. Mulla, V. R. Salunke, and S. B. Bhise, “Hepatoprotective activity of hydroalcoholic extract of leaves of Alocasia indica (Linn.),” Indian Journal of Experimental Biology, vol. 47, pp. 816-821, 2009.
S. K. Singh, et al., “A review paper on Alocasia macrorrhiza tradional Indian medicinal plant,” European Journal of Pharmaceutical and Medical Research, vol. 4, pp. 366-375, 2017.
K. Islam, et al., “Preliminary pharmacological evaluation of Alocasia indica Schott tuber,” Journal of Intergrative Medicine, vol. 11, pp. 343-351, 2013.
V. Srivastava, et al., “Biological activities of Alocasia macrorrhiza: A review,” Journal of Science, vol. 2, pp. 22-29, 2012.
T. K. Lim, “Alocasia macrorrhizos, ”Edible Medicinal and Non Medicinal Plants, vol. 9, pp. 429-442, 2015.
T. N. Quyet, et. al., “ New ceramide from Alocasia macrorrhiza,” Arch Pharm Res, vol. 27, pp. 1020–1022, 2004
T. N. Quyet et al., “Two New Aloceramides From Alocasia machrorrhiza,” Journal of Chemistry, vol. 43, pp. 513-516, 2005.
L. Zhu, et al., “Indole alkaloids from Alocasia machrorrhiza,” Cherm. Pharm. Bull, vol. 60, pp. 670-673, 2012, 2012.
W. Huang, et al., “Piperidine alkaloids from Alocasia macrorrhiza,” Phytochemistry, vol. 143, pp. 81-86, 2017.
W. Huang, et al., “Anti-inflammatory lignanamides and monoindoles from Alocasia machrorrhiza,” Fitoterapia, vol. 117, pp. 126-132, 2017.
A. Nahrstedt, “Cyanogenese der araceen,” Phytochemistry, vol. 14, pp. 1339-1340, 1974.
W. Hosel and O. Klewitz, “Beta-glucosidases specific for the cyanogenic glucoside triglochinin from Alocasia macrorrhiza Schott: further characterization of proper-ties,” Hoppe Seylers Z Physiol Chem, vol. 358, pp. 959–966, 1977.
W. Hosel and A. Nahrstedt, “Glucosidases specific for the cyanogenic glucoside triglochinin. Purification and characterization of beta-glucosidases from Alocasia macrorrhiza Schott,” Hoppe Seylers Z Physiol Chem, vol. 356, pp. 1265–1275, 1975.
M. E. Ernst, Pharm. D., and Marvin Moser, M.D., “Use of diuretics in patients with hypertension,” Journal of Medicine, vol. 361, pp. 2153-2164, 2009.
F. C. Bart’ter and W. B. Schwartz, “The syndrome of inappropriate secretion of antidiuretic hormone,” American Journal of Medicine, vol. 42, pp. 790-806, 1967.
E. B. Verney, F. R. S., “The antidiuretic hormone and the factors which determine its release,” JSTOR, pp. 25-206, 1947.
U. S. Mubeen, M.Vimlesh, and B. Santanu, “Laxative and Diuretic Property of Ethanolic Extract of Leaves of Alocasia macrorrhiza Linn. on Experimental Albino Rats,” International Research Journal of Pharmacy, vol. 3, pp. 174-176, 2012.
S. R. Kane, et al., “Diuretic and laxative activity of ethanolic extract and its fractions of Euphorbia Thymifolia Linn,” International Journal of Chem Tech Research, vol. 1, pp. 149-152, 2009.
V. Beljanski, L. G. Marzilli and P. W. Doetsch, “DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs,” Molecular Pharmacology, vol. 65, pp. 1496-1506, 2005.
Y. Liu, et al., “Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction,” Journal of Neurochemistry, vol. 69, pp. 581-593, 1997.
K. Abe and N. Matsuki, “Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT,” Neuroscience Research, vol. 38, pp. 325–329, 2000.
J. van Meerloo, GJ. Kaspers, and J. Cloos, “Cell sensitivity assays: the MTT assay,” Methods Mol Biol, vol. 731, pp. 237-245, 2011.
S. Fang, et al., “Anticancer otential of aqueous extract of Alocasia macrorrhiza against hepatic cancer in vitro and in vivo,” Journal of Ethnopharmacology, vol. 141, pp. 947– 956, 2012.
Z. Jun, “Anticancer effects of diffenent solvent extracts from Alocasia Macrorrhiza in vitro,” Lishizhen Medicine and Materia Medica Research, 2008.
M. L. Wahlqvist, MD., et al., “Antioxidant relevance to human health,” Asia Pac J Clin Nutr Mini Review, vol. 22, pp. 171-176, 2013.
P. Molyneux, “The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity,” J. Sci. Technol., vol. 26, pp. 211-219, 2004.
V. Bondet, W. B. Williams, and C. Berset, “Kinetics and mechanisms of antioxidant activity using the DPPH free radical method” Lebensm.-Wiss. u.-Technol., vol. 30, pp. 609-615, 1997.
Om. P. Sharma, and Tej K. Bhat, “DPPH antioxidant assay revisited,” Journal of Food Chemistry, vol. 113, pp. 1202-1205, 2009.
K. Mishra, Ojha, and N. K. Chaudhury, “Estimation of antiradical properties of antioxidants using DPPH Assay: A critical review and results,” Food Chemistry, vol. 130, pp. 1036-1043, 2012.
P. Mandal, T. K. Misra and I. D. Singh, “Antioxidant activity in the extracts of two edible aroids,” Indian Journal of Pharmaceutical Science, vol. 72, pp. 105-108, 2010.
M. Zasioff, “Antimicrobial peptides of multicellular organisms,” Nature, vol. 415, pp. 389-395, 2002
J. L. Rıos, and M. C. Recio, “Medicinal plants and antimicrobial activity,” Journal of Ethnopharmacology, vol. 100, pp. 80-84, 2005.
M. M. Cowan, “Plant products as antimicrobial agents,” Clinical Microbiology Reviews, vol. 12, pp. 564-582, 1999.
M. R. S. Zaidan, et al., “In vitro screening of five local medicinal plants for antibacterial activity using disc diffusion method,” Tropical Biomedicine, vol. 22, pp. 165–170, 2005.
W. A. Mulla, et al., “Evaluation of antimicrobial activity of leaves of Alocasia Indica Linn.,” International Journal of PharmTech Research, vol. 2, pp. 327-333, 2010.
A. Tokajuk, et al., “Antidiabetic drugs and risk of cancer,” Pharmacological Reports, vol. 67, pp. 1240-1250, 2015.
N. Malviya, S. Jain, and S. Malviya, “Antidiabetic potential of medicinal plants,” Acta Poloniae Pharmaceutic-Drug Research: Review, vol. 67, pp. 113-118, 2010.
R. Karim, et al., “A study on antidiabetic activity of the leaf and stem of Alocasia indica L. in steptozotocin induced diabetic rats,” International Journal of Biosciences, vol. 5, pp. 195-202, 2014.
T. Jawaid, S. Argal, and M. Kamal, “Antidiabetic and antihyperlipidemic effcets of the ethanolic extract of Alocasia indica rhizomes in high fat diet/streptozotocin and streptozotocin/nicotinamide-induced type 2 diabetic rats,” Asian J Pharm Clin Res., vol 8, pp. 58-62, 2015
S. H. Patil, et al., “Antidiabetic and hypolipidemic potential of Alocasia indica Schott. leaves in streptozotocin induced diabetic rats,” International Journal of Drug Development and Research, vol. 4, pp. 368-374, 2012.
M. C. Bertoluci, et al., “Urinary TGF-β1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy,” Diabetes Research and Clinical Practice, vol. 72, pp. 258-264, 2006.
A. Y. Y. Cheng, and I. G. Fantus, “Oral antihyperglycemic therapy for type 2 diabetes miilitus,” Review Synthese: Canadian Medical Association or its Licensor, vol. 172, pp. 213-226, 2005.
N. Vergnolle, “The inflammatory response,” Drug Development Research, vol. 59, pp. 375-381, 2003.
A. Rahman, et al., “Analgesic and anti-inflammatory activities of Alocasia indica (Roxb.) Schott,” Oriental Pharmacy and Experimental Medicine, vol. 11. Pp. 143-146, 2011.
W. A. Mulla, et al., “Antioxidant, antinociceptive and anti-inflammatory activities of ethanolic extract of leaves of Alocasia indica (Schott.),” J Young Pharm., vol. 2, pp. 138-143, 2010.
P. Yadav, and R. Singh, “A review on anthelmintic drugs and their future scope,” International Journal Of Pharmacy and Pharmaceutical Sciences, vol. 3, pp. 17-21, 2011.
R. Kaminsky, et al., “A New class of anthelmintics effective against drug-resistant nematodes,” Nature, vol. 452, pp. 176-181, 2008.
L. H. Dye and R. J. Walker, “Anthelmentic drug,”. The C. elegans Research Community, 1-12, 2007.
S. H. Patil, et al., “Anthelmintic activity of Alocasia indica Schott. rootstocks,” International Journal of Drug Development & Research, vol. 4, pp. 211-214, 2012.
W. A. Mulla, et al., “Anthelmintic activity of leaves of Alocasia indica Linn,” International Journal of Pharmtech Research, vol. 2, pp. 26-30, 2010.
K. G. Brandt, M. M. de C. Antunes, and Giselia Alves Pontes da Silva, “Acute diarrhea: Evidence-based management,” Journal de Pediatria, vol. 91, pp. S36-S43, 2015.
F. Awouters, C J. E. Niemegeers, and P. A. J. Janssen, “Pharmacology of antidiarrheal drugs,” Annu. Rev. Pharmacol. Toxicol, vol.23, pp. 279-301, 1983.
W. A. Mulla, et al., “Evaluation of antidiarrheal and in vitro antiprotozoal activities of extracts of leaves of Alocasia indica,” Research Article of Pharm B io, vol. 49, pp. 354-61, 2011.
DOI: http://dx.doi.org/10.12962/j25493736.v3i1.3494
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.